| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Benevich Eric is a Chief Commercial Officer at NBIX. Recent filings cover 0 purchases and 61 sales. Those positions are worth an estimated $10.5M at current prices.
Our model assigns Benevich Eric a middling insider score of 62/100, based on 26 past trades. Over a 12-month horizon, 44.0% of those trades were profitable, with an average 12-month return of -5.9%.
Benevich Eric's largest disclosed position is in NBIX as Chief Commercial Officer, worth about $10.5M. The recent filings there lean toward selling, a net 383,298 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | NBIX Neurocrine Biosciences, Inc. | Chief Commercial Officer | Sale+OE | 2,154 | $154.61 | $333,029.94 | -3.2% | - | - | |
| Nov 28, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 5,970 | $151.74 | $905,880.64 | -11.7% | -14.1% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 2,154 | $116.73 | $251,427.64 | -4.6% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 980 | $118.31 | $115,940.37 | -2.2% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 1,207 | $152.94 | $184,598.58 | -2.8% | -29.8% | -10.4% | |
| Apr 15, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 19,818 | $133.36 | $2,643,019.64 | -32.7% | +11.9% | -27.0% | |
| Mar 14, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 75,000 | $139.38 | $10,453,417.50 | -64.8% | -3.3% | -20.4% | |
| Feb 28, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 75,000 | $134.69 | $10,101,607.50 | -64.9% | +4.3% | -12.7% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,098 | $133.01 | $146,050.36 | -2.6% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 2,260 | $138.68 | $313,418.67 | -5.4% | +3.4% | -8.8% |